Menu Search
Equities

Sigma Healthcare Ltd

S5YA:BER

Sigma Healthcare Ltd

Actions
  • Price (EUR)1.47
  • Today's Change0.07 / 5.00%
  • Shares traded--
  • 1 Year change+255.30%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.

  • Revenue in AUD (TTM)3.56bn
  • Net income in AUD-3.00m
  • Incorporated1999
  • Employees156.00
  • Location
    Sigma Healthcare LtdLevel 6, 2125 Dandenong Road, ClaytonMELBOURNE 3168AustraliaAUS
  • Phone+61 39215-9215
  • Fax+61 39215-9188
  • Websitehttps://sigmahealthcare.com.au/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SIG:ASX since
announced		Transaction
value
CW Group Holdings LtdAnnounced11 Dec 202311 Dec 2023Announced227.03%5.45bn
Data delayed at least 20 minutes, as of Nov 21 2024 05:10 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.